Takeda and HemoShear partner to discover new treatments for liver diseases

Japan ’s Takeda Pharmaceutical Company has collaborated with US-based biotechnology company HemoShear Therapeutics to discover and develop new therapeutics for liver diseases, including non-alcoholic steatohepatitis (NASH).
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news